PAVmed (PAVM) Return on Capital Employed (2016 - 2025)

PAVmed's Return on Capital Employed history runs 10 years deep, the most recent figure standing at 92.39% for Q4 2025.

• In Q4 2025, Return on Capital Employed fell 74146.0% year-over-year to 92.39%; the TTM figure through Dec 2025 stood at 92.39% (down 74146.0% YoY), while the FY2025 annual figure was 109.58%, down 136045.0% from the prior year.
• Return on Capital Employed was 92.39% for Q4 2025 at PAVmed, down from 66.16% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 1157.5% in Q3 2023 to a low of 1010.82% in Q1 2023.
• Historically, Return on Capital Employed has averaged 26.81% across 5 years, with a median of 93.56% in 2025.
• Biggest YoY gain for Return on Capital Employed was 139988 bps in 2023; the steepest drop was 91406 bps in 2023.
• A 5-year view of Return on Capital Employed shows it stood at 94.73% in 2021, then plunged by 337 bps to 413.61% in 2022, then jumped by 200 bps to 414.25% in 2023, then soared by 57 bps to 649.07% in 2024, then tumbled by 114 bps to 92.39% in 2025.
• The last three Return on Capital Employed figures came in at 92.39% (Q4 2025), 66.16% (Q3 2025), and 76.7% (Q2 2025), per Business Quant data.